SYNOLIGO
Live / Registered — Registered (as of 12 Mar 2024)
What this means for you
Registered since 12 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97668963
- Registration number
- 7329395
- Mark type
- Stylized text
- Filed
- 09 Nov 2022
- Published for opposition
- 10 Oct 2023
- Registered
- 12 Mar 2024
Goods and services
- Class 001 — Chemicals: Chemicals and chemical preparations, namely, oligonucelotide, for research and diagnostic and/or therapeutic use other than for medical or veterinary purposes; nucleic acid reagents for diagnostic purposes except for medical or veterinary purposes
- Class 005 — Pharmaceuticals: Nucleic acid reagents for medical, veterinary, and medical and veterinary diagnostic purposes; Chemicals and chemical preparations for therapeutic medical and veterinary purposes
Owner
- Synoligo Biotechnologies, Inc., Morrisville, NC, US
- Synoligo Biotechnologies, Inc., Morrisville, NC, US
- Synoligo Biotechnologies, Inc., Morrisville, NC, US
Prosecution history
- 12 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 08 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Jan 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Dec 2023 — USE AMENDMENT FILED
- 13 Jan 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Dec 2023 — TEAS STATEMENT OF USE RECEIVED
- 05 Dec 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Oct 2023 — PUBLISHED FOR OPPOSITION
- 20 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Aug 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Aug 2023 — EXAMINER'S AMENDMENT ENTERED
- 28 Aug 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED